Latest Breaking News On - Company or werewolf nasdaq - Page 1 : comparemela.com

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRandi isaacsJosh rappaportEllen lubmanJustin moserAmerican society of clinical oncologyScientific communicationsWerewolf therapeutics incExchange commissionGlobenewswire incCompany contactHonorhealth research instituteCompany or werewolf nasdaqClinical oncologyAnnual meetingAssociate clinical investigator

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesEllen lubmanRandi isaacsJosh rappaportDanielj hicklinGlobenewswire incScientific communicationsWerewolf therapeutics incCompany contactCompany or werewolf nasdaqChief executive officerChief medical officerGlobal healthcare conferenceYork cityWerewolf therapeutics

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesEllen lubmanDanielj hicklinJosh rappaportDuring the american association of immunologists meetingExchange commissionScientific communicationsDrug administrationJazz pharmaceuticalsPacific western bankWerewolf therapeutics incCompany contactAmerican association of immunologists meetingCompany or werewolf nasdaqAmerican society for clinical oncologyTherapeutics reports first quarter

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024

Company to present an update of its ongoingmonotherapy and combinationPhase 1/1b study of WTX-124 in advanced or metastatic solid tumors

United statesJosh rappaportEllen lubmanCompany contactCompany or werewolf nasdaqScientific communicationsExchange commissionWerewolf therapeutics incAmerican society of clinical oncologyClinical oncologyAnnual meetingNon hodgkin lymphomaPrivate securities litigation reform act

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJosh rappaportEllen lubmanExchange commissionWerewolf therapeutics incAmerican society of clinical oncologyScientific communicationsCompany contactCompany or werewolf nasdaqAbstract acceptedClinical oncologyAnnual meetingNon hodgkin lymphomaPrivate securities litigation reform act